Urinalysis Market Growing Burden of Urinary Tract Infection, Diabetes, and Kidney Diseases Boosts Market Growth

A urinalysis is used in the diagnosis and management of various disorders such as kidney disease, urinary tract infections, and diabetes. It is the analysis of urine by chemical, physical, and microscopical means to check for the presence of drugs and disease-related entities, including biomolecules or other by-products, in it. The urinalysis includes checking the concentration, appearance, and content of urine. In urinalysis, abnormal results or estimations out of the expected range may indicate an illness or disease. If the urine test result is positive, it may point that kidneys are not functioning or filtering the blood in the manner as they should. It might also help in the diagnosis of cardiovascular disease, and detection of pregnancy and ovulation.

Get sample PDF Copy along with table of content at: https://www.theinsightpartners.com/sample/TIPHE100001381/?utm_source=OpenPR&utm_medium=10144

The urinalysis market is projected to reach US$ 5,937.97 million by 2028 from US$ 4,065.79 million in 2021; it is expected to grow at a CAGR of 5.6% from 2021 to 2028.

Abbott; ACON Laboratories, Inc.; ARKRAY, Inc; Beckman Coulter, Inc.; Bio-Rad Laboratories Inc.; Cardinal Health Inc.; F. Hoffmann-La Roche Ltd.; Quidel Corporation; Siemens Healthineers AG; and Sysmex Corporation are among the leading companies operating in the urinalysis market.

The urinalysis market, by application, is segmented into disease screening and pregnancy, and fertility. The disease screening segment is expected to account for a larger market share in 2021. The urinalysis market for the disease screening segment is estimated to grow at a higher CAGR from 2021 to 2028.

COVID-19 has presented the most significant global health emergency till date. Lockdowns resulting from the COVID-19 pandemic caused people to delay undergoing health checkups, thus affecting the number of tests being performed and sales of instruments, consumables, and reagents. The urinalysis market witnessed a shortfall at the beginning of the COVID-19 crisis due to disruption in supply chain and demand due to the lockdown announced by most European countries. However, a resurgence in testing numbers is seen as countries gradually ease restrictions on movement.

Based on end user, the urinalysis market is segmented into hospitals and clinics, diagnostic laboratories, home care settings, and research laboratories and institutes. The hospitals and clinics segment would hold the largest share of the market in 2021, while the diagnostic laboratories segment is estimated to register the highest CAGR during the forecast period.

As per the study reported by a group of researchers at the American College of Physicians and Infectious Diseases Society of America in 2020, ~6 million people in the US visit physicians for the treatment of urinary tract infection (UTIs) every year. Women are at a higher risk of developing UTIs than men. According to a study published in the International Journal of Environmental Research and Public Health in 2019, patients with existing chronic conditions, such as diabetes mellitus (DM), are at a greater risk of acquiring UTIs.

Place an Order copy of this report at: https://www.theinsightpartners.com/buy/TIPHE100001381/?utm_source=OpenPR&utm_medium=10144

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense, Food & beverage, Chemical and Materials, Semiconductors etc.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com

This release was published on openPR.